Baseline characteristics

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma · Source last updated 2024-10-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      123

   2. group Id

      BG001

      value

      239

   3. group Id

      BG002

      value

      152

   4. group Id

      BG003

      value

      514

   units

   Participants

groups

1. description

   Eligible participants with TCR MM, who were BCMA naïve, who were enrolled between 2 February 2021 to 07 January 2022 and who were treated with elranatamab in study C1071003 were included.

   id

   BG000

   title

   C1071003 Cohort A

2. description

   Eligible participants with TCR MM who were treated with SOC therapies in real world clinical practice setting, identified from COTA database were included. This arm served as external control arm.

   id

   BG001

   title

   RWD: COTA

3. description

   Eligible participants with TCR MM who were treated with SOC therapies in real world clinical practice setting, identified from Flatiron Health database were included. This arm served as external control arm.

   id

   BG002

   title

   RWD: Flatiron Health

4. description

   Total of all reporting groups

   id

   BG003

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            9.4

            value

            67.1

         2. group Id

            BG001

            spread

            9.4

            value

            68.0

         3. group Id

            BG002

            spread

            10.0

            value

            69.5

         4. group Id

            BG003

            spread

            9.6

            value

            68.2

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   Years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            55

         2. group Id

            BG001

            value

            109

         3. group Id

            BG002

            value

            72

         4. group Id

            BG003

            value

            236

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            68

         2. group Id

            BG001

            value

            130

         3. group Id

            BG002

            value

            80

         4. group Id

            BG003

            value

            278

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            72

         2. group Id

            BG001

            value

            175

         3. group Id

            BG002

            value

            102

         4. group Id

            BG003

            value

            349

         title

         White

      2. measurements

         1. group Id

            BG000

            value

            51

         2. group Id

            BG001

            value

            64

         3. group Id

            BG002

            value

            50

         4. group Id

            BG003

            value

            165

         title

         Non-white

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race/Ethnicity, Customized

   unit Of Measure

   Participants

population Description

Eligible participants whose data was included for observation in this study.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice